Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Q301--Lab Testing Services - clonoSEQ Measurable Residual Disease Test Pittsburgh VA Medical Center - Pittsburgh, PA

Active
36C24426Q0855Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Department of Veterans Affairs’ Network Contracting Office 4 intends to award a sole source contract to Adaptive Biotechnologies Corporation for the provision of clonoSEQ Measurable Residual Disease (MRD) testing services at the Pittsburgh VA Medical Center. This action is justified under FAR 6.103-1 because Adaptive Biotechnologies is the exclusive provider of the clonoSEQ assay, a proprietary, FDA-cleared, and CLIA-validated molecular test used to detect MRD in patients with multiple myeloma, B-cell acute lymphoblastic leukemia, chronic lymphocytic leukemia, diffuse large B-cell lymphoma, and other lymphoid malignancies. The contract will use simplified acquisition procedures, be firm fixed price, and span a five-year period with an annual quantity of 100 tests. The solicitation number is 36C24426Q0855, and the NAICS code is 621511 with a size standard of $41.5 million. Any interested party may submit a capability statement prior to the response deadline of August 10, 2026, at 8:00 AM Eastern Standard Time, but the Government retains full discretion to proceed without competition based on the unique nature of the technology and the absence of viable alternatives. Responses must include the company name, SAM UEI number, address, point of contact details, business size, and evidence demonstrating the ability to perform the service, including relevant experience, contract numbers, dollar amounts, performance periods, and customer contacts. All submissions must be emailed to Mickeya Linzie at mickeya.linzie@va.gov and must clearly state whether the respondent is the direct provider or an authorized reseller. No submissions will be accepted after the deadline, and all information provided becomes the property of the Government.

General Info

Sole source contract to Adaptive Biotechnologies for clonoSEQ MRD testing at Pittsburgh VA, five years, 100 tests annually.

Agency

Department Of Veterans Affairs → 244-NETWORK Contract Office 4 (36C244)View Agency

NAICS

621511 - Medical LaboratoriesView NAICS

Place of Performance

PA

Set-Aside

NONE

Documents

(1)

36C24426Q0855.docx

DOCX

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

Posted

special-notice

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → 244-NETWORK Contract Office 4 (36C244)
Contacts1 person available
OfficePITTSBURGH, PA, 15215, USA
Organization / Agency
Department Of Veterans Affairs → 244-NETWORK Contract Office 4 (36C244)
View Agency Profile
Office AddressPITTSBURGH, PA, 15215, USA
Contacts
Mickeya LinzieContracting Officer

Full Description

Show more
NOTICE OF INTENT TO AWARD SOLE SOURCE: The Department of Veterans Affairs (VA) Regional Procurement Office East (RPOE), Network Contracting Office 4 (NCO 4) intends to award a sole source contract pursuant to RFO FAR 6.103-1 to Adaptive Biotechnologies Corporation located at 1165 Eastlake AVE E, Seattle, Washington 98109. Simplified acquisition procedures will be used, and the resulting contract will be firm priced for a five-year period.
The Pittsburgh VA Medical Center requires a contractor to provide clonoSEQ Measurable Residual Disease (MRD) Testing. This service shall be provided for the Department of Veterans Affairs, Pittsburgh VA Medical Center, located at University Drive, Pittsburgh, PA 15240. The clonoSEQ assay is provided exclusively by Adaptive Biotechnologies and is a proprietary, FDA-cleared, patented molecular test developed and performed exclusively by Adaptive Biotechnologies for MRD detection in bone marrow from patients with multiple myeloma and B-cell acute lymphoblastic leukemia (B-ALL), and in blood or bone marrow from patients with chronic lymphocytic leukemia (CLL). It is also a CLIA-validated laboratory developed (LDT) test for diffuse large B-cell lymphoma (DLBCL) and other lymphoid malignancies. Adaptive Biotechnologies is the sole source provider of clonoSEQ MRD testing within the United States. It is the Government's belief that only the proposed candidate possesses the required capabilities to successfully meet the VA facility s needs.
Line Item Description Annual Quantity 1 ClonoSEQ MRD Testing 100
THIS NOTICE IS NOT A REQUEST FOR COMPETITIVE QUOTES; however, any responsible firm that believes it can meet the requirement shall give written notification and capability statements prior to the response due date and time. Vendors shall indicate if they are the direct supplier or service provider of the items and/or authorized reseller/distributor. Supporting evidence shall be furnished in sufficient detail to demonstrate the ability to perform the requirement and shall include relevant experience along with the applicable contract number(s), total contract dollar amount, contract period of performance, details of the relevant supply and/or services, and customer point of contact with corresponding telephone number and email address.
Responses shall include following information: 1. Company Name 2. SAM UEI Number 3. Company s Address 4. Point of Contact Information (title, phone number and email address) 5. Business Size
Responses received will be evaluated; however, a determination by the Government not to compete the proposed procurement based on responses to this notice is solely within the discretion of the Government. Information provided will not be returned. Responses are due by Monday, 8/10/2026 at 8:00 AM Eastern Standard Time. No submissions will be accepted after this date and time. Responses shall be submitted via email to Mrs. Mickeya Linzie at mickeya.linzie@va.gov.
The NAICS code for this acquisition is 621511 (Medical Laboratories) and the size standard is $41.5 million.

Similar Contracts

Same NAICS industry code

NAICS: 621511
New
Federal
Biochemical and Metabolic Testing ServicesThe contract seeks specialized biochemical and metabolic testing services to support the diagnosis of rare metabolic and mitochondrial disorders in undiagnosed patients, with a focus on amino acid profiling, organic acid analysis, and enzyme assays. These analyses are critical for identifying underlying biochemical abnormalities that may not be detectable through standard diagnostic methods, enabling more accurate clinical decision-making and personalized patient care. The work is to be performed at the designated location in Bethesda, Maryland, with a performance timeframe aligned with the federal funding cycle and regulatory requirements for clinical diagnostic laboratories. This subcontract is issued under the National Institutes of Health, Office of Laboratory Animal Welfare, and falls under the NAICS code 621511 for medical and diagnostic laboratories. The opportunity was posted on July 28, 2026, with a response deadline of August 7, 2026, and is part of a broader effort by the Department of Health and Human Services to expand diagnostic capabilities for complex genetic and metabolic conditions. While no specific set-aside provisions are indicated, the subcontractor must possess the technical expertise, validated methodologies, and regulatory compliance necessary to deliver high-confidence results in a clinical research environment.
National Institutes Of Health Olao

POSTED

4 days ago

DEADLINE

in 6 days
View Details
NAICS: 621511
New
Federal
Clinical Genetic Testing and Interpretation ServicesThe contract calls for the provision of CLIA-certified genetic testing services, specifically focusing on whole exome sequencing and the generation of interpretive reports that connect identified genetic variants to clinical phenotypes for the diagnosis of rare diseases. The work must be performed in compliance with all applicable clinical laboratory standards and requires the technical expertise to analyze complex genomic data and deliver actionable, clinically relevant interpretations. The services are intended to support diagnostic efforts within a research or clinical setting, with deliverables centered on accurate, evidence-based reporting that aids in patient care and rare disease identification. This is a subcontract under the National Institutes of Health, part of the Department of Health and Human Services, with performance required at the Bethesda location with a zip code of 20892. The solicitation was posted on July 28, 2026, and responses are due by August 7, 2026, with a NAICS code of 621511 indicating it falls under medical and diagnostic laboratories. There is no set-aside designation noted, and the contract does not include specific point of contact details, but interested parties must adhere to the submission deadline and ensure full compliance with CLIA and clinical reporting standards to be considered for award.
National Institutes Of Health Olao

POSTED

4 days ago

DEADLINE

in 6 days
View Details
NAICS: 621511
New
Federal
172 AW Lab Services IDIQ
Solicitation # W50S7H26RA001
The U.S. Air Force’s 172d Airlift Wing is soliciting proposals for a five-year, firm-fixed-price Indefinite-Delivery, Indefinite-Quantity (IDIQ) contract under solicitation number W50S7H-26-R-A001 to obtain comprehensive medical laboratory testing services. This is a 100% small business set-aside with a size standard of $41.5 million, targeted at NAICS code 621511 for medical laboratories. Proposals must be submitted electronically by August 26, 2026, and must include a detailed price schedule covering all services listed in the Performance Work Statement, formatted in MS Excel or PDF. Pricing must reflect unit costs for all five years of the ordering period, and any transaction fees associated with Government Purchase Card (GPC) use must be explicitly stated—otherwise, no surcharges will be assumed. The contract will be awarded using the Best Value Trade-Off process under FAR 13.5 and Part 12, prioritizing technical capability and past performance over price, though price remains a critical component evaluated for reasonableness and balance. Technical proposals must demonstrate compliance with CLIA/CAP certifications, a clear operational plan for sample collection and turnaround times within a Sunday-through-Saturday 0730–1600 window, and confirmation that all laboratory facilities are within 30 minutes’ drive of the 172d Airlift Wing and strictly within the Jackson MSA. Orders under the resulting IDIQ will be placed using either the GPC for transactions up to $25,000 or DD Form 1155 Delivery Orders for amounts above that threshold, with electronic funds transfer processed through WAWF. GPC usage is the primary execution method for low-value orders to accelerate payment cycles, and only authorized cardholders designated by the 172d Medical Group may issue such orders. Contractors must accept both GPC and Delivery Order payment mechanisms, and all invoicing must comply with WAWF requirements, including the use of specified DoDAACs for payment routing. The evaluation process will rate technical capability as the most critical factor, with subfactors for licensing, operational capability, and geographic compliance acting as gatekeepers—failure in any one will render a proposal unacceptable. Past performance will be assessed for relevance and recency within the past three years, and price will be analyzed for total evaluated cost based on estimated volumes
W7NH Uspfo Activity Msang 172

POSTED

4 days ago

DEADLINE

in 25 days
View Details
NAICS: 621511
New
Federal
Q515--MO - HLA Testing - 626 Tennessee Valley Healthcare System HLA Transplant Testing Services POP: 10/1/2026-9/30/2032
Solicitation # 36C24926R0076
The Department of Veterans Affairs, through Network Contracting Office 9, has issued a solicitation for HLA Transplant Testing Services to support the Tennessee Valley Healthcare System in Nashville, Tennessee. The contract has a performance period extending from October 1, 2026, through September 30, 2032, and is identified by solicitation number 36C24926R0076 under NAICS code 621511 and Product Service Code Q515. Proposals are due by August 24, 2026, with submissions to be directed to the contracting office located in Murfreesboro, Tennessee. The primary point of contact is Contract Specialist Rebecca Espinoza, reachable via email at rebecca.espinoza@va.gov. The place of performance is the Tennessee Valley Healthcare System’s facility at 1310 24th Avenue South, Nashville, TN 37212. The solicitation is for specialized clinical laboratory services critical to organ transplant compatibility assessments, though detailed specifications, deliverables, evaluation factors, pricing terms, and contractual clauses have not yet been released in the available documentation. Information regarding inspection criteria, packaging and labeling requirements, quality standards such as CLIA or CAP, invoicing procedures, accounting data, key personnel qualifications, and special requirements including security clearances or organizational conflict of interest provisions remain unspecified and are expected to be detailed in the full solicitation package when published. No set-aside status has been designated, and no attachment lists, contract clauses, or evaluation factors are currently accessible. All cost information, line-item details, and submission formatting instructions are pending release. Offerors must await the official solicitation for comprehensive guidance on compliance, technical requirements, and award methodology.
249-NETWORK Contract Office 9 (36C249)

POSTED

4 days ago

DEADLINE

in 23 days
View Details
NAICS: 621511
New
Federal
Clinical Laboratory Testing and Specialized Biochemical AnalysisServices for the NHGRI Undiagnosed Diseases Program (UDP) through Baylor Genetics Laboratory
Solicitation # 75N98026Q00900
The contract entails the provision of CLIA-certified clinical laboratory testing and specialized biochemical analysis services for the National Human Genome Research Institute’s Undiagnosed Diseases Program, under NIH protocol 15-HG-0130, through Baylor Genetics Laboratory. The work supports the evaluation of patients with complex, rare, and previously undiagnosed multisystem disorders, focusing on genetic, metabolic, and mitochondrial conditions. Services include advanced testing such as mitochondrial DNA copy number quantification, assessment of mitochondrial deletions, metabolomic profiling, biochemical pathway analysis, and testing of tissues including muscle, liver, fibroblasts, blood, and urine, along with follow-up family studies when authorized. All testing must adhere to federal and state regulations, using validated methodologies and maintained quality assurance systems to ensure accuracy and compliance. The contractor is required to deliver comprehensive laboratory reports with clinical interpretations and limitations within established turnaround times, using secure, privacy-compliant transmission methods. Immediate notification of critical or clinically significant findings is mandatory to support urgent patient care. Technical consultation services are essential, including guidance on test selection, specimen handling, result interpretation, and recommendations for additional testing. The contractor must also actively participate in scientific and clinical discussions as requested by NIH. The solicitation, numbered 75N98026Q00900, is issued by the National Institutes of Health within the Department of Health and Human Services, with responses due by August 7, 2026, and performance primarily based in Bethesda, Maryland.
National Institutes Of Health Olao

POSTED

4 days ago

DEADLINE

in 6 days
View Details

More opportunities from Department Of Veterans Affairs → 244-NETWORK Contract Office 4 (36C244)

Same awarding agency

NAICS: 621991
New
Federal
6506--Notice of Intent to Sole Source - Lab Supplies (Blood) Erie VA Medical Center - Erie, PA
Solicitation # 36C24426Q0612
The Department of Veterans Affairs, through the Network Contracting Office 4 in Pittsburgh, intends to award a sole source contract to the Community Blood Bank of Northwest Pennsylvania & Western New York for the supply of blood and blood components and specialized immunohematology reference laboratory services to the Erie VA Medical Center. The contract will be awarded under simplified acquisition procedures using firm pricing over a five-year period, with the sole justification being the vendor’s unique ability to deliver critical blood products within one hour of notification due to its proximity to the medical center. The required items include leukoreduced packed red blood cells, pathogen-reduced platelets, fresh frozen plasma, washed and re-washed red blood cells, and an annual immunohematology reference service, along with associated tariff surcharges and after-hours delivery fees. All responsible vendors are invited to submit written capability statements prior to the deadline of August 10, 2026, at 8:00 AM Eastern Time, demonstrating their ability to meet the requirement, including direct supplier confirmation, relevant contract history, performance details, and customer contacts. Responses must include the company name, SAM UEI number, address, point of contact information, and business size certification. The acquisition falls under NAICS code 621991 with a $40 million size standard, and submissions must be sent via email to the designated contracting officer. The government retains full discretion to proceed with sole source award regardless of any responses received, and no submissions will be accepted after the deadline.
Blood and Organ Banks

POSTED

about 20 hours ago

DEADLINE

in 9 days
View Details
NAICS: 325998
New
Federal
Bagged Ice Melt Supply (Calcium Chloride or CMA-Based, ≤-25°F Performance)The contract requires the supply of bagged ice melt in weatherproof packaging, formulated to perform effectively at temperatures as low as -25°F, and must be delivered in either pellet or granular form. The product must be engineered to be safe for concrete surfaces and surrounding vegetation, with a strict requirement to prevent clumping under storage or environmental exposure. Each shipment must be palletized in units of exactly 24 bags per pallet to ensure uniform handling and distribution. The ice melt must be based on either calcium chloride or CMA, meeting specified performance standards without compromising safety or efficiency. This is a subcontract under a Small Business Set Aside classification, specifically reserved for small businesses, with the NAICS code 325998 indicating it falls under Other Chemical Product and Preparation Manufacturing. The solicitation was posted on July 28, 2026, with a firm response deadline of August 11, 2026, at 8:00 PM. The place of performance is designated with a zip code of 16504, and the contracting office is the 244-NETWORK Contract Office 4 under the Department of Veterans Affairs. All submissions must comply fully with the technical and logistical specifications outlined, and only eligible small business concerns may respond to this solicitation.
All Other Miscellaneous Chemical Product and Preparation Manufacturing

POSTED

4 days ago

DEADLINE

in 11 days
View Details
NAICS: 484220
New
Federal
Cold Chain Logistics and Blood TransportationThe contract encompasses cold chain logistics and blood transportation services exclusively within Pittsburgh, ensuring the secure and temperature-controlled movement of blood units between collection sites, laboratories, storage facilities, and VA medical centers. This subcontract requires adherence to strict environmental controls throughout the entire supply chain to maintain the viability and safety of blood products during transit, with operations tailored to meet the rigorous standards of medical logistics in a healthcare environment. The performance location is fixed in Pittsburgh, and the work is governed under NAICS code 484220, which classifies the activity as specialized truck transportation for refrigerated goods. The contract is managed by the Department of Veterans Affairs through its 244-NETWORK Contract Office 4, indicating alignment with federal veterans’ healthcare infrastructure and priorities. Although details regarding set-asides, point of contact, or specific performance metrics are not provided, the timing of the posting in 2026 suggests this is a forward-looking procurement likely intended to establish or reinforce long-term logistical support for blood supply operations in the region. The nature of the work demands reliable, compliant, and continuous service capable of handling time-sensitive medical materials with zero tolerance for temperature deviation or delay.
Specialized Freight (except Used Goods) Trucking, Local

POSTED

4 days ago

DEADLINE

N/A
View Details
NAICS: 541519
New
Federal
DA10 - Notice of Intent to Sole-Source - Subscription and Support for DSS, Inc. Iconic Data PCM HRO Inpatient Care
Solicitation # 36C24426F0374
The Network Contracting Office 4 under the Department of Veterans Affairs intends to award a sole source contract exclusively to Minburn Technology Group, LLC for the continued licensing, maintenance, and support of the DSS Iconic Data PCM HRO Inpatient Care with Suicide Prevention system at the Philadelphia VA Medical Center. This action is justified under unusual and compelling urgency authorities and will be conducted using simplified acquisition procedures via a firm fixed-price order from NASA SEWP. The contract duration is limited to no more than six months, and the procurement is not open to competition, as determined solely by the government under statutory provisions permitting sole source awards in urgent circumstances. The North American Industry Classification System code for this effort is 541519, and the contract will be awarded under solicitation number 36C24426F0374. Although a notice of intent has been issued with a response deadline of July 30, 2027, this is not a solicitation for proposals and no competitive quotations are being sought. A formal sole source justification will be made publicly available with the award notice. The point of contact for inquiries is Nathan Lohr of the Network Contracting Office 4 based in Pittsburgh, Pennsylvania, with services to be performed at the Philadelphia VA Medical Center located in Philadelphia, Pennsylvania, zip code 19104.
Other Computer Related Services

POSTED

4 days ago

DEADLINE

in 12 months
View Details